Clinical Biochemistry — MCQs

Clinical Biochemistry Indian Medical PG Practice Questions and MCQs

Question 201: Which of the following enzyme assays is useful to diagnose alcoholism?

A. SGOT (Correct Answer)
B. SGPT
C. Alkaline phosphatase
D. Glutamyl aminotransferase

Explanation: In clinical biochemistry, the ratio and specific elevation of aminotransferases are key to diagnosing alcoholic liver disease. **Why SGOT (AST) is the correct answer:** In alcoholic hepatitis, **SGOT (Aspartate Aminotransferase)** is typically elevated more than SGPT (Alanine Aminotransferase). This occurs because alcohol is a direct mitochondrial toxin. Since SGOT has both cytosolic and mitochondrial isoenzymes, mitochondrial damage leads to a greater release of SGOT. Furthermore, alcoholics often have a deficiency of **Pyridoxal-5-phosphate (Vitamin B6)**; while both enzymes require B6 as a cofactor, the synthesis of SGPT is much more sensitive to this deficiency, leading to lower SGPT levels compared to SGOT. A **De Ritis Ratio (AST:ALT) > 2:1** is highly suggestive of alcoholic liver disease. **Analysis of Incorrect Options:** * **SGPT (ALT):** This is a more specific marker for general liver cell injury (as it is primarily found in the liver cytosol), but in alcoholism, it remains lower than SGOT. * **Alkaline Phosphatase (ALP):** This is primarily a marker for cholestasis or bone turnover. While it may rise in alcoholic cirrhosis, it is not a specific diagnostic marker for alcoholism itself. * **Glutamyl aminotransferase:** This is a distractor term. The relevant enzyme is **Gamma-glutamyl transferase (GGT)**, which is the most sensitive (though less specific) screening marker for chronic alcohol consumption. **High-Yield Clinical Pearls for NEET-PG:** * **AST:ALT > 2:1** = Alcoholic Liver Disease. * **AST:ALT < 1** = Non-Alcoholic Fatty Liver Disease (NAFLD) or Viral Hepatitis. * **GGT** is the most sensitive marker for detecting occult alcohol use and monitoring abstinence. * Alcoholism also causes an increase in **MCV (Macrocytosis)** and **Serum Triglycerides**.

Question 202: What are the typical sweat chloride levels in fibrocystic disease of the pancreas?

A. Elevated (Correct Answer)
B. Decreased
C. First elevated then decreased
D. First decreased then elevated

Explanation: **Explanation:** **Fibrocystic disease of the pancreas**, commonly known as **Cystic Fibrosis (CF)**, is an autosomal recessive disorder caused by mutations in the **CFTR (Cystic Fibrosis Transmembrane Conductance Regulator)** gene. **Why the answer is Elevated:** The CFTR protein functions as a chloride channel. In the **sweat glands**, its primary role is the **reabsorption** of chloride ions from the primary secretion back into the ductal cells. When CFTR is defective, chloride cannot be reabsorbed and remains in the sweat. To maintain electrical neutrality, sodium reabsorption is also impaired. This results in an abnormally high concentration of sodium and chloride in the sweat (often described by parents as the child "tasting salty"). **Analysis of Incorrect Options:** * **B. Decreased:** This is incorrect because the defect prevents the removal of chloride from the sweat duct; it does not stop chloride from entering the sweat initially. * **C & D (Fluctuating levels):** Sweat chloride levels in CF patients remain consistently elevated from birth. They do not follow a temporal pattern of increasing or decreasing as the disease progresses. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Diagnostic Test:** The **Pilocarpine Iontophoresis Sweat Test**. * **Diagnostic Threshold:** A sweat chloride concentration **>60 mmol/L** on two separate occasions is diagnostic for CF. * **The "CFTR Paradox":** Remember that while CFTR failure leads to *decreased* chloride secretion in the lungs and pancreas (causing thick mucus), it leads to *decreased* chloride reabsorption in sweat glands (causing high sweat chloride). * **Common Mutation:** The most frequent mutation is **ΔF508** (deletion of phenylalanine at position 508).

Question 203: Aminopeptidase is elevated in obstruction of which of the following?

A. Ureter
B. Urethra
C. Common Bile Duct (CBD) (Correct Answer)
D. Bladder

Explanation: **Explanation:** The correct answer is **Common Bile Duct (CBD)**. **Leucine Aminopeptidase (LAP)** is a proteolytic enzyme found in various tissues, but its clinical significance lies primarily in the hepatobiliary system. It is located on the canalicular membrane of hepatocytes and the luminal surface of biliary epithelial cells. 1. **Mechanism of Elevation:** In cases of **cholestasis** or **obstructive jaundice** (such as a stone or tumor in the Common Bile Duct), the increased pressure within the biliary tree and the detergent action of accumulated bile salts cause the release of membrane-bound enzymes into the circulation. Therefore, LAP levels rise significantly in CBD obstruction, mirroring the pattern of Alkaline Phosphatase (ALP). 2. **Why other options are wrong:** Options A, B, and D refer to the urinary tract. While LAP is present in the kidneys, its elevation in the serum is not a marker for urinary tract obstructions (Ureter, Urethra, or Bladder). Obstructions here typically lead to hydronephrosis or renal failure, marked by elevations in Creatinine and BUN, not LAP. **NEET-PG High-Yield Pearls:** * **LAP vs. ALP:** LAP is often used to differentiate the source of an elevated Alkaline Phosphatase. Both rise in hepatobiliary disease, but **LAP remains normal in bone disease**. If a patient has high ALP but normal LAP, the pathology is likely skeletal (e.g., Paget’s disease). * **Other Cholestatic Markers:** Along with LAP and ALP, **5'-Nucleotidase** and **Gamma-glutamyl transferase (GGT)** are key markers for biliary obstruction. * **Pregnancy Note:** LAP levels may also rise physiologically during the last trimester of pregnancy.

Question 204: Which of the following tests is used to assess long-term diabetic status?

A. Random blood sugar
B. Fasting blood sugar
C. Glycated hemoglobin (Correct Answer)
D. Glucometer

Explanation: **Explanation:** **Glycated hemoglobin (HbA1c)** is the gold standard for assessing long-term glycemic control. It reflects the average blood glucose levels over the preceding **8 to 12 weeks** (the average lifespan of a red blood cell). The underlying biochemical process is **non-enzymatic glycation**, where glucose molecules bond to the N-terminal valine of the hemoglobin beta chain. Because this process is irreversible and proportional to the ambient glucose concentration, it provides a stable "memory" of blood sugar levels, unaffected by recent meals or short-term fluctuations. **Why other options are incorrect:** * **Fasting Blood Sugar (FBS) and Random Blood Sugar (RBS):** These provide a "snapshot" of the blood glucose at a specific moment. They are used for diagnosis and acute monitoring but cannot reflect long-term status as they are influenced by immediate factors like diet, exercise, and stress. * **Glucometer:** This is a device used for Point-of-Care Testing (POCT) to monitor daily capillary blood glucose. It is used for self-monitoring and adjusting immediate insulin doses, not for assessing long-term control. **High-Yield Clinical Pearls for NEET-PG:** * **Diagnostic Cut-off:** According to ADA criteria, an **HbA1c ≥ 6.5%** is diagnostic for Diabetes Mellitus. * **Fructosamine Test:** Measures glycated albumin and reflects glycemic control over the past **2–3 weeks**. It is the preferred test when HbA1c is unreliable (e.g., in patients with Hemolytic Anemia or Thalassemia). * **False Low HbA1c:** Seen in conditions that decrease RBC lifespan (Pregnancy, Hemolytic anemia, recent blood transfusion). * **False High HbA1c:** Seen in conditions that increase RBC lifespan or alter glycation (Iron deficiency anemia, Splenectomy).

Question 205: A 50-year-old patient presents with symptomatic nephrolithiasis. He reports that he underwent a jejunoileal bypass for morbid obesity at age 39. Which of the following is a complication of jejunoileal bypass?

A. Pseudohyperparathyroidism
B. Hyperuric aciduria
C. Hungry bone syndrome
D. Hyperoxaluria (Correct Answer)

Explanation: **Explanation:** The correct answer is **Hyperoxaluria**. This patient is suffering from **Enteric Hyperoxaluria**, a well-known complication of malabsorptive procedures like jejunoileal bypass or Crohn’s disease. **Mechanism:** Under normal physiological conditions, dietary calcium binds to oxalate in the intestinal lumen to form insoluble **calcium oxalate**, which is excreted in the feces. However, in malabsorptive states (like post-bypass), unabsorbed free fatty acids reach the colon and bind to calcium (saponification). This leaves dietary oxalate "unbound" and free for absorption into the bloodstream. This excess oxalate is then filtered by the kidneys, leading to **calcium oxalate nephrolithiasis**. **Analysis of Incorrect Options:** * **A. Pseudohyperparathyroidism:** This is a paraneoplastic syndrome (usually due to PTHrP secretion by tumors) and is unrelated to intestinal bypass surgery. * **B. Hyperuric aciduria:** While gout can occur in obesity, the specific mechanism of stone formation post-bypass is driven by oxalate metabolism, not primary uric acid overproduction. * **C. Hungry bone syndrome:** This refers to profound hypocalcemia seen *after* a parathyroidectomy in patients with long-standing hyperparathyroidism; it is not a direct complication of bypass surgery. **NEET-PG High-Yield Pearls:** * **The "Calcium-Fat" Competition:** In fat malabsorption, fats "steal" calcium from oxalate. * **Treatment:** Management includes a low-oxalate diet and **calcium carbonate supplements** taken with meals to bind oxalate in the gut. * **Other Bypass Complications:** Vitamin B12 deficiency, Vitamin D deficiency (leading to secondary hyperparathyroidism, not pseudo), and bacterial overgrowth.

Question 206: What is the preferably desirable level for cholesterol in an abnormal person?

A. 200 mg/dl (Correct Answer)
B. 180 mg/dl
C. 150 mg/dl
D. 120 mg/dl

Explanation: **Explanation:** The classification of serum cholesterol levels is based on the guidelines provided by the **National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP III)**. These guidelines are high-yield for NEET-PG as they define the thresholds for diagnosing and managing dyslipidemia. **1. Why Option A is Correct:** According to NCEP ATP III guidelines, a total cholesterol level of **less than 200 mg/dl** is classified as **"Desirable."** This level is associated with a lower risk of developing coronary artery disease (CAD). Levels between 200–239 mg/dl are considered "Borderline High," and levels ≥240 mg/dl are "High." Therefore, 200 mg/dl is the standard clinical benchmark for a desirable upper limit. **2. Why Other Options are Incorrect:** * **Options B, C, and D (180, 150, 120 mg/dl):** While these levels are physiologically healthy and technically "desirable" (as lower is generally better for total cholesterol), they do not represent the **standardized clinical cutoff** used in medical examinations and guidelines to define the "desirable" category. In MCQ formats, you must select the specific threshold defined by international guidelines. **Clinical Pearls for NEET-PG:** * **LDL Cholesterol:** The "Bad Cholesterol." Desirable level is **<100 mg/dl**. It is the primary target of lipid-lowering therapy (Statins). * **HDL Cholesterol:** The "Good Cholesterol." Levels **<40 mg/dl** are considered a major risk factor for heart disease, while **≥60 mg/dl** is considered protective. * **Triglycerides:** Normal level is **<150 mg/dl**. * **Friedewald Formula:** (Used to calculate LDL) → $LDL = Total\ Cholesterol - HDL - (Triglycerides/5)$. *Note: This formula is invalid if TG >400 mg/dl.*

Question 207: Which of the following is NOT a marker of bone resorption?

A. Tartrate resistant acid phosphatase
B. Osteocalcin (Correct Answer)
C. Cross-linked N-telopeptides
D. Urine total free deoxypyridinoline

Explanation: Markers of bone turnover are divided into two categories: **Markers of Bone Formation** (reflecting osteoblast activity) and **Markers of Bone Resorption** (reflecting osteoclast activity). ### Why Osteocalcin is the Correct Answer **Osteocalcin** is a non-collagenous protein synthesized by **osteoblasts** during the bone mineralization process. It is a specific marker of **bone formation**. Since the question asks for a marker that is *NOT* related to bone resorption, Osteocalcin is the correct choice. ### Explanation of Incorrect Options (Resorption Markers) * **A. Tartrate-resistant acid phosphatase (TRAP):** This is an enzyme secreted specifically by **osteoclasts**. Its serum levels correlate with the number and activity of osteoclasts, making it a classic resorption marker. * **C. Cross-linked N-telopeptides (NTx):** During bone resorption, Type I collagen is degraded. NTx is a specific breakdown product released into the blood and urine, serving as a highly sensitive marker of bone resorption. * **D. Urine total free deoxypyridinoline (DPD):** Pyridinoline and Deoxypyridinoline are cross-links that stabilize collagen fibers in the bone matrix. When bone is resorbed, these are released and excreted in the urine unchanged. ### High-Yield Clinical Pearls for NEET-PG * **Bone Formation Markers:** Serum Alkaline Phosphatase (bone-specific isoenzyme), Osteocalcin, and Procollagen type 1 N-terminal propeptide (P1NP). * **Bone Resorption Markers:** Urinary Hydroxyproline, Serum/Urine NTx and CTx (C-telopeptides), and TRAP 5b. * **Gold Standard:** **P1NP** is considered the most sensitive marker for bone formation, while **Serum CTx** is the preferred marker for bone resorption in clinical practice. * **Clinical Use:** These markers are used to monitor response to osteoporosis therapy (e.g., Bisphosphonates) rather than for primary diagnosis.

Question 208: What is the primary biochemical marker for primary hyperparathyroidism?

A. Hypercalcemia (Correct Answer)
B. Hypophosphatemia
C. Increased alkaline phosphatase levels
D. Increased ACTH

Explanation: **Explanation:** **Primary Hyperparathyroidism (PHPT)** is most commonly caused by a solitary parathyroid adenoma (85%), leading to the autonomous overproduction of Parathyroid Hormone (PTH). **1. Why Hypercalcemia is the correct answer:** PTH is the chief regulator of calcium homeostasis. In PHPT, elevated PTH levels act on three main targets to increase serum calcium: * **Bone:** Increases osteoclastic resorption, releasing calcium into the ECF. * **Kidneys:** Increases distal tubular reabsorption of calcium. * **Intestines:** Stimulates the synthesis of 1,25-dihydroxyvitamin D (Calcitriol) in the kidneys, which enhances intestinal calcium absorption. **Hypercalcemia** is the biochemical hallmark and often the first clinical sign detected on routine screening. **2. Analysis of Incorrect Options:** * **B. Hypophosphatemia:** While PTH decreases renal phosphate reabsorption (leading to phosphaturia), hypophosphatemia is a *secondary* finding and is not present in all patients. Hypercalcemia remains the primary diagnostic marker. * **C. Increased Alkaline Phosphatase (ALP):** ALP levels are only elevated in cases with significant bone involvement (Osteitis fibrosa cystica). Many modern PHPT patients are asymptomatic with normal ALP. * **D. Increased ACTH:** ACTH is related to adrenal/pituitary axis disorders (e.g., Cushing’s disease) and has no direct role in parathyroid pathology. **High-Yield Clinical Pearls for NEET-PG:** * **Classic Triad:** Hypercalcemia, elevated PTH, and low-to-normal phosphate. * **Mnemonic for Symptoms:** "Stones (renal calculi), Bones (aches/fractures), Groans (abdominal pain/peptic ulcers), and Psychic Moans (depression/confusion)." * **Urinary Finding:** Hypercalciuria (despite PTH increasing reabsorption, the filtered load of calcium exceeds the renal threshold). * **X-ray Finding:** Subperiosteal resorption of phalanges and "Salt and pepper" appearance of the skull.

Question 209: Which of the following is a reactive oxygen species but not a free radical?

A. Hydroxy radical
B. Hydrogen peroxide (Correct Answer)
C. Superoxide radical
D. Both hydroxy radical and hydrogen peroxide

Explanation: ### Explanation The distinction between **Reactive Oxygen Species (ROS)** and **Free Radicals** is a high-yield concept in biochemistry. **Why Hydrogen Peroxide ($H_2O_2$) is the correct answer:** A **Free Radical** is defined as any molecular species capable of independent existence that contains one or more **unpaired electrons** in its outer shell. While all free radicals derived from oxygen are ROS, not all ROS are free radicals. $H_2O_2$ is a highly reactive oxidizing agent, but it contains **no unpaired electrons** in its molecular orbitals. Therefore, it is a Reactive Oxygen Species but **not** a free radical. **Analysis of Incorrect Options:** * **A. Hydroxy radical ($OH^\bullet$):** This is the most reactive and damaging free radical known in biological systems. It possesses an unpaired electron. * **C. Superoxide radical ($O_2^{\bullet-}$):** This is the "primary" ROS produced by the electron transport chain (Complex I and III). It contains one unpaired electron, making it a true free radical. * **D. Both hydroxy radical and hydrogen peroxide:** Incorrect because the hydroxy radical is a free radical. **Clinical Pearls for NEET-PG:** 1. **Fenton Reaction:** $H_2O_2$ reacts with $Fe^{2+}$ to produce the highly toxic Hydroxy radical ($OH^\bullet$). This is a key mechanism in iron-overload cell injury. 2. **Haber-Weiss Reaction:** Superoxide reacts with $H_2O_2$ to generate $OH^\bullet$. 3. **Antioxidant Defense:** $H_2O_2$ is neutralized by **Catalase** (in peroxisomes) and **Glutathione Peroxidase** (in cytoplasm/mitochondria). 4. **Other Non-Radical ROS:** Singlet oxygen ($^1O_2$) and Hypochlorous acid ($HOCl$).

Question 210: Abnormal excretory function of hepatocytes may be assessed by which of the following?

A. Increased Prothrombin Time (PT)
B. Increased Alanine Aminotransferase (ALT)
C. Increased Alkaline Phosphatase (Correct Answer)
D. All of the above

Explanation: ### Explanation Liver function tests (LFTs) are categorized based on what they measure: **synthetic function**, **hepatocellular integrity**, or **excretory (cholestatic) function**. **1. Why "Increased Alkaline Phosphatase" is correct:** Alkaline Phosphatase (ALP) is an enzyme found in the epithelial cells lining the bile canaliculi. When the **excretory function** of the liver is impaired (as seen in cholestasis or biliary obstruction), the increased pressure and bile salts stimulate the synthesis and release of ALP into the bloodstream. Therefore, elevated ALP is a hallmark of obstructive jaundice and impaired excretory capacity. **2. Why other options are incorrect:** * **Increased Prothrombin Time (PT):** This is a marker of the liver's **synthetic function**. The liver synthesizes clotting factors (I, II, V, VII, IX, X). A prolonged PT indicates either acute liver failure or chronic cirrhosis, reflecting the liver's inability to produce proteins, not its excretory status. * **Increased Alanine Aminotransferase (ALT):** This is a marker of **hepatocellular integrity**. ALT is an intracellular enzyme; its elevation signifies leakage due to cell membrane damage (hepatocyte necrosis or inflammation), as seen in viral hepatitis. **3. High-Yield Clinical Pearls for NEET-PG:** * **Excretory Markers:** ALP and GGT (Gamma-Glutamyl Transferase). If both are high, the source is likely hepatic. If only ALP is high, consider bone disease. * **Specific Marker:** ALT is more specific for the liver than AST (Aspartate Aminotransferase). * **Synthetic Markers:** Serum Albumin (chronic) and Prothrombin Time (acute/best prognostic marker). * **Bilirubin:** Conjugated hyperbilirubinemia is a classic sign of impaired excretory function.

Practice by Chapter

Liver Function Tests

Practice Questions

Kidney Function Tests

Practice Questions

Cardiac Markers and Enzymes

Practice Questions

Pancreatic Function Tests

Practice Questions

Glucose Tolerance Tests

Practice Questions

Lipid Profile and Cardiovascular Risk

Practice Questions

Tumor Markers

Practice Questions

Hormonal Assays and Interpretation

Practice Questions

Electrolytes and Acid-Base Balance Tests

Practice Questions

Cerebrospinal Fluid Analysis

Practice Questions

Point-of-Care Testing

Practice Questions

Quality Control in Clinical Biochemistry

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free